TipRanks
Advertisement
Advertisement

IMTX Stock Latest News

Immatics Raises $161 Million in Completed Equity Offering to Advance PRAME Cancer Programs
Company AnnouncementsImmatics Raises $161 Million in Completed Equity Offering to Advance PRAME Cancer Programs
24d ago
6K
IMTX
Immatics price target lowered to $17 from $18 at Jefferies
PremiumThe Fly
Immatics price target lowered to $17 from $18 at Jefferies
26d ago
IMTX
Immatics announces $150M offering of common stock priced at $8.69 per share
PremiumThe Fly
Immatics announces $150M offering of common stock priced at $8.69 per share
26d ago
IMTX
Morning Movers: Klarna sinks following second quarter results, trimmed guidance
PremiumThe Fly
Morning Movers: Klarna sinks following second quarter results, trimmed guidance
1M ago
AS
FN
Immatics Posts Interim Q2 2026 Results and Updates Investor Materials
PremiumCompany Announcements
Immatics Posts Interim Q2 2026 Results and Updates Investor Materials
1M ago
6K
IMTX
Immatics reports Q2 EPS (46c), consensus (48c)
PremiumThe FlyImmatics reports Q2 EPS (46c), consensus (48c)
1M ago
IMTX
Immatics N.V. (IMTX) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Immatics N.V. (IMTX) Q2 Earnings Cheat Sheet
1M ago
IMTX
Immatics Shareholders Approve All Proposals at June 18, 2026 AGM
Premium
Company Announcements
Immatics Shareholders Approve All Proposals at June 18, 2026 AGM
3M ago
6K
IMTX
Immatics Calls 2026 Annual General Meeting, Sets Record Date and Details New Incentive Plan
PremiumCompany Announcements
Immatics Calls 2026 Annual General Meeting, Sets Record Date and Details New Incentive Plan
4M ago
6K
IMTX
Immatics Showcases Strong Phase 1 Data for PRAME and MAGEA4/8 TCR Programs at ASCO 2026
PremiumCompany Announcements
Immatics Showcases Strong Phase 1 Data for PRAME and MAGEA4/8 TCR Programs at ASCO 2026
4M ago
6K
IMTX
Immatics announces presentation of extended data from Phase 1 trial of IMA401
PremiumThe Fly
Immatics announces presentation of extended data from Phase 1 trial of IMA401
4M ago
IMTX
Immatics announces updated Phase 1 data for its Prame TCR T-cell therapy
PremiumThe Fly
Immatics announces updated Phase 1 data for its Prame TCR T-cell therapy
4M ago
IMTX
Immatics reports Q1 EPS (43c), consensus (44c)
PremiumThe FlyImmatics reports Q1 EPS (43c), consensus (44c)
4M ago
IMTX
Immatics Widens Q1 2026 Loss as Collaboration Revenue Drops, R&D Spend Climbs
Premium
Company Announcements
Immatics Widens Q1 2026 Loss as Collaboration Revenue Drops, R&D Spend Climbs
4M ago
6K
IMTX
Immatics initiated with a Buy at TD Cowen
Premium
The Fly
Immatics initiated with a Buy at TD Cowen
5M ago
IMTX
Immatics Secures Four High-Profile Oral Slots for PRAME and Bispecific Programs at 2026 ASCO
PremiumCompany Announcements
Immatics Secures Four High-Profile Oral Slots for PRAME and Bispecific Programs at 2026 ASCO
5M ago
6K
IMTX
Immatics Highlights PRAME-Targeted Cell Therapy Remission in Pediatric Kidney Cancer, Plans Pediatric Trial Expansion
PremiumCompany Announcements
Immatics Highlights PRAME-Targeted Cell Therapy Remission in Pediatric Kidney Cancer, Plans Pediatric Trial Expansion
5M ago
6K
IMTX
Immatics abstract accepted for late-breaking poster presentation at AACR meeting
PremiumThe Fly
Immatics abstract accepted for late-breaking poster presentation at AACR meeting
5M ago
IMTX
Immatics assumed with a Buy at Jefferies
PremiumThe Fly
Immatics assumed with a Buy at Jefferies
6M ago
IMTX
Immatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance
PremiumCompany AnnouncementsImmatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance
7M ago
6K
IMTX
Immatics sees cash runway into 2028
Premium
The Fly
Immatics sees cash runway into 2028
7M ago
IMTX
Immatics reports FY25 EPS (EUR 1.61) vs. EUR 0.14 last year
Premium
The Fly
Immatics reports FY25 EPS (EUR 1.61) vs. EUR 0.14 last year
7M ago
IMTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >